David P. Snow files SEC Form 4 disclosures for Eloxx Pharmaceuticals, Inc.. They have made 1 open-market trade across 1 company since 2015, most recently 2020-02-29.
CIK 0001652972
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $419K since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RDUS | BUY | 2015-09-14 | 2015-09-28 | $69.79 | $419K | -33.2% | -2.6% | -2.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.